Form 4 for LRCX Lam Research
Accepted 2026-09-03 15:06:03 ET · period of report 2026-09-02 · accession 0001707827-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-03 15:06 | 2026-09-02 | LRCX | Varadarajan Seshasayee | SVP | S - Sale+OE | $291.32 | -59.8K | 205.5K | -23% | -$17.41M |
| DMT | 2026-09-03 15:06 | 2026-09-02 | LRCX | Varadarajan Seshasayee | SVP | M - OptEx | $39.25 | +39.8K | 233.0K | +21% | +$1.56M |
| DMT | 2026-09-03 15:06 | 2026-09-02 | LRCX | Varadarajan Seshasayee | SVP | M - OptEx | $0.00 | -39.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-02 | S | D | 20,000 | $291.32 | 205,546 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 2 | Common | Common Stock | 2026-09-02 | M | A | 12,270 | $59.88 | 217,816 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 3 | Common | Common Stock | 2026-09-02 | S | D | 12,270 | $291.32 | 205,546 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 4 | Common | Common Stock | 2026-09-02 | M | A | 27,480 | $30.03 | 233,026 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 5 | Common | Common Stock | 2026-09-02 | S | D | 27,480 | $291.32 | 205,546 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2026. (F2) The amount reported includes shares subject to unvested restricted stock units. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2026-09-02 | M | D | 12,270 | $0.00 | 0 | D | $59.88 · — to 2028-03-01 | 12,270 Common Stock | (F3) The stock options will become exercisable in three equal installments on 03/01/2022, 03/01/2023, and 03/01/2024. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2026-09-02 | M | D | 27,480 | $0.00 | 0 | D | $30.03 · — to 2027-03-02 | 27,480 Common Stock | (F4) The stock options will become exercisable in three equal installments on 03/02/2021, 03/02/2022, and 03/02/2023. |